Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Bronchiectasis Rhinovirus Challenge to Define Immunopathogenesis of Exacerbation

NCT06931002 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT06931002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06931002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Bronchiectasis Rhinovirus Challenge to Define Immunopathogenesis of Exacerbation
Lead sponsor
Imperial College London
Phase
Not applicable
Overall status
Recruiting
Start date
July 24, 2024
Completion date
October 30, 2027
Enrollment
54 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiectasis adult, bronchiectasis with acute exacerbation, bronchiectasis with chronic infection with pseudomonas aeruginosa, rhinovirus infection, viral infection